| Product Information |
|
| Registration Number |
BR-1436
|
| Generic Name |
Atezolizumab
|
| Brand Name |
Tecentriq
|
| Dosage Strength |
1200 mg/20 mL (60 mg/mL)
|
| Dosage Form |
Concentrate for Solution for
Infusion (IV)
|
| Classification |
Prescription Drug (RX)
|
| Pharmacologic Category |
-
|
| Packaging |
20 mL Type I colorless borosilicate glass vial with
fluororesin-laminated rubber stopper and aluminum seal with flip-off cap (Box of 1's).
|
| Manufacturer |
F. Hoffmann-La Roche AG
|
| Country of Origin |
Switzerland
|
| Trader |
F. Hoffmann-La Roche Ltd.
|
| Importer |
Roche (Philippines), Inc.
|
| Distributor |
Roche (Philippines), Inc.
|
| Application Type |
Monitored Release
|
| Issuance Date |
11 January 2023
|
| Expiry Date |
11 January 2028
|